HLA antigens in subacute sclerosing panencephalitis patients in Israel.
HLA Class I antigens were determined in the 49 subacute sclerosing panencephalitis (SSPE) patients. In analyzing the Arabs and the Jews separately, there is a decrease in HLA-A2 in the Jewish patients (X2 = 3.96; P less than 0.05), a significant increase in the HLA-A29 in the Arab SSPE patients (X2 = 6.29; P less than 0.02), and a slight, insignificant increase of HLA-A29 in the Jewish patients. The present study supports previous findings of Kurent's and needs following studies in larger groups of Arab SSPE patients.
Kahana
E
E
Neurology Unit, Barzilai Medical Center, Ashkelon, Israel.
Brautbar
C
C
D002648:Child; D003431:Cross-Cultural Comparison; D005006:Ethnicity; D005787:Gene Frequency / Q000235:genetics; D006680:HLA Antigens / Q000032:analysis / Q000235:genetics*; D015234:HLA-A Antigens / Q000235:genetics; D015235:HLA-B Antigens / Q000235:genetics; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D007557:Israel; D007585:Jews / Q000235:genetics; D009460:Neurologic Examination; D012307:Risk Factors; D013344:Subacute Sclerosing Panencephalitis / Q000208:ethnology / Q000235:genetics* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015395:Histocompatibility Antigens Class I